Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-15.45	19.22	22.73
Graham Fair Price	195.26	83609.06	28317.10
PEG	-97.77	< 0.005	-0.21
Price/Book	-17.91	0.50	0.60
Price/Cash Flow	-54.19	61.76	-134.83
Prices/Earnings	-90.32	3.59	37.15
Price/Sales	-14.32	3.00	3.51
Price/FCF	-54.19	61.76	-134.83
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.96	0.10	0.09
Operating Margin	31.48	0.03	0.02
ROA	720.55	0.03	< 0.005
ROE	< 0.005	0.03	748.31
ROIC	< 0.005	< 0.005	1004.45
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	4.98	-0.19	2590.73
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.76	0.28	-63.52
EPS QOQ	1.75	7.60	333.47
FCF QOQ	-1.39	2.82	102.17
Revenue QOQ	0.03	-0.03	14.58
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	73.97	70.51	-4.68
Days Sales Outstanding (DSO)	120.63	59.85	-50.39
Inventory Turnover	1.22	1.28	4.91
Debt/Capitalization	< 0.005	< 0.005	-2.87
Quick Ratio	3.62	2.79	-22.83
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	93569.13	94855.18	1.37
Cash	18396.36	22868.48	24.31
Capex	-2192.77	-2083.49	4.98
Free Cash Flow	-419.80	762.65	81.67
Revenue	16147.04	15682.93	-2.87
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.77	3.77	-21.01
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.94	-5.72	42.44
Naive Interpretation	Member

06 - Financial Health · Bad

Rating